RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Common stock and paid-in capital

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.6B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Sep 30, 20258,415+2.56%
Sep 30, 20248,205-0.04%
Sep 30, 20238,208+0.00%
Sep 30, 20228,208+0.00%
Sep 30, 20218,208-14.85%
Sep 30, 20209,640+0.00%
Sep 30, 20199,640+9.27%
Sep 30, 20188,822+0.00%
Sep 30, 20178,822+0.00%
Sep 30, 20168,822+0.00%
Sep 30, 20158,822+0.00%
Sep 30, 20148,822

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)